Daily for 6 weeks Subcutaneous injection near the abdomen or fatty tissue
It's popular in biohacking circles and often pops up in patient consults, but the FDA hasn't approved it for human therapy
Expert Pharmacist Support Have questions about reconstitution, dosing, or compatibility
Supplier and the exact listing name, including the fill size, rather than just the compound name Lot identifier, and the date the batch documentation was issued Date received, and the storage conditions and location it went into Date of reconstitution, the diluent used and its lot, and the volume actually added Nominal concentration obtained, stated as nominal rather than as measured Aliquot scheme: how many, what volume, stored where Freeze-thaw count for each aliquot at the point of use Any deviation from plan, including deviations that seemed unimportant at the time Whether the material was research-use-only labeled, which for this listing it is Comparing suppliers on this exact SKU Comparing BPC-157 + GHK-Cu + TB-500 across suppliers on price alone is comparing two numbers that may not describe the same thing
For experimental designs that need both axes covered in parallel, see our full BPC-157 + TB-500 dosing protocol and the BPC-157 vs TB-500: how the two peptides compare guide